Press Releases | Medtronic

Month Year

Email alerts

Nov 17, 2011

Bain Capital to Acquire Physio-Control from Medtronic

MINNEAPOLIS & BOSTON--(BUSINESS WIRE)--Nov. 17, 2011-- Medtronic, Inc. (NYSE:MDT) and Bain Capital, a leading global private investment firm, today announced they have entered into a definitive...
Nov 17, 2011

Medtronic Receives FDA Approval of AdaptiveStim(TM) with RestoreSensor(TM) for the Management of Chronic Pain

Neurostimulator Uses Innovative Motion Sensor Technology to Provide Patient Comfort and Convenience

MINNEAPOLIS--(BUSINESS WIRE)--Nov. 17, 2011-- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food & Drug Administration (FDA) approval of its AdaptiveStim™ with RestoreSensor™...
Nov 10, 2011

Actress and Dancer Debbie Allen Teams Up With Medtronic and Urges Americans to "Join the Pace Makers"

Campaign Empowers People With a Slow Heartbeat to Learn About Treatment Options and How to Have an Informed Discussion With Their Doctor

Famed dancer, actress, and director Debbie Allen has teamed up with Medtronic, Inc. (NYSE: MDT) today to kick off "Join the Pace Makers," a national campaign designed to empower people with a...
Nov 9, 2011

Retrospective Study Shows New Device Significantly Reduces Blood Loss and Transfusions in Adolescent Scoliosis Corrective Surgery

MINNEAPOLIS, Nov 09, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today reported results of an retrospective study available online and in an upcoming print edition of the Journal of Spinal...
Nov 9, 2011

Medtronic Begins Enrolling U.S. IDE Study of EnliteTM Sensor for Continuous Glucose Monitoring

Study Will Evaluate Accuracy of Latest Innovation to Help People with Diabetes Improve Glucose Control

MINNEAPOLIS, Nov 09, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced a new United States investigational device exemption study to evaluate the accuracy of six-day use in...
Nov 8, 2011

Medtronic Resolute(R) Drug-Eluting Stent Shows Strong Results, Even in Challenging Diabetes Patients with Coronary Disease

Pooled Data Analyses to Be Presented at TCT 2011 Demonstrate Heart Device's Consistently Positive Performance Across Multiple Clinical Studies

SAN FRANCISCO, Nov 08, 2011 (BUSINESS WIRE) -- Currently under review by the U.S. Food and Drug Administration (FDA), the Resolute(R) drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT)...
Nov 8, 2011

Study of Medtronic Endeavor(R) Drug-Eluting Stent Demonstrates Long-Term Advantages over Taxus(R) DES

Final Five-Year Follow-up of Randomized ENDEAVOR IV Trial Shows Durable Safety and Efficacy of Endeavor DES, with Comparatively Lower Rates of Cardiac Death/Myocardial Infarction and Very Late Stent Thrombosis

SAN FRANCISCO, Nov 08, 2011 (BUSINESS WIRE) -- New research findings released at TCT 2011 show that the Endeavor(R) zotarolimus-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT) outperformed...
Nov 7, 2011

Medtronic CoreValve(R) System Gains CE Mark for New Direct Aortic Approach to Transcatheter Aortic Valve Implantation

New Access Will Expand Treatment Options for Patients with Severe Aortic Stenosis

MINNEAPOLIS, Nov 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for the Medtronic CoreValve(R) System to be delivered...
Nov 4, 2011

Medtronic's Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

Presentations Cover Stents and Balloons for Coronary and Peripheral Artery Disease, Transcatheter Valve for Aortic Stenosis, Stent Grafts for Aortic Aneurysms, and Renal Denervation for Treatment-Resistant Hypertension and Heart Failure

MINNEAPOLIS, Nov 04, 2011 (BUSINESS WIRE) -- Offering the broadest range of medical technology for the interventional and surgical treatment of cardiovascular disease, Medtronic, Inc. (NYSE: MDT)...
Nov 3, 2011

Medtronic Announces Global Launch of the T2 ALTITUDE(TM) Expandable Corpectomy Device

The latest advancement in expandable cage technology for surgeons, hospitals and patients

MEMPHIS, Tenn., Nov 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) announced the global launch of the T2 ALTITUDE(TM) Expandable Corpectomy Device in the U.S. and Europe today at the North...

Show per page